RESUMO
The aims of this single centre study were to assess the feasibility of related cord blood collecting, the appropriateness of storage and the final suitability for transplantation. Since September 1994, 63 families were enrolled in this study. Families were eligible if they were caring for a patient with a disorder treatable by haematopoietic stem cell transplantation and were experiencing a pregnancy. A total of 72 cord blood units were collected and stored for 64 patients (both siblings and parents). We focussed on human leucocyte antigen (HLA) compatibility and cell content as critical requirements to unit's suitability for transplantation. HLA-typing was carried out for 34 donor-recipient couples and most units (72%) mismatched with the related patients. About 60% of collections had a minimum cell dose considered acceptable for transplantation. Only 21% of units had both compatibility degree and cell content suitable for transplantation. When applicable, information on the compatibility degree between the foetus and the patient should be obtained during pregnancy. Appropriateness of related cord blood banking for parents should be further investigated and cost-effective guidelines policies should be provided. Finally, as banking of related cord blood units is an important resource then, this public service should be supported and enhanced.
Assuntos
Bancos de Sangue/organização & administração , Preservação de Sangue , Transplante de Células-Tronco de Sangue do Cordão Umbilical , Criopreservação , Sangue Fetal/citologia , Obtenção de Tecidos e Órgãos/organização & administração , Adolescente , Adulto , Doenças da Medula Óssea/cirurgia , Criança , Pré-Escolar , Transplante de Células-Tronco de Sangue do Cordão Umbilical/estatística & dados numéricos , Estudos de Viabilidade , Feminino , Antígenos HLA/análise , Doenças Hematológicas/cirurgia , Hemoglobinopatias/genética , Hemoglobinopatias/cirurgia , Histocompatibilidade , Humanos , Lactente , Recém-Nascido , Masculino , Pessoa de Meia-Idade , Pais , Gravidez , Estudos Prospectivos , Irmãos , Adulto JovemAssuntos
Criopreservação/normas , Sangue Fetal , Criopreservação/economia , Feminino , Humanos , Recém-Nascido , Gravidez , Controle de QualidadeRESUMO
We prospectively studied the chimaerism status in the bone marrow (BM) and peripheral blood (PB) of 23 patients receiving umbilical cord (UCB, 14 cases) or BM (nine cases) transplants from unrelated donors by PCR amplification of four individual-specific VNTR genetic loci. Haematological engraftment, with persistent full donor pattern. was observed in 10/14 (72%) patients receiving UCB and in 9/9 (100%) patients transplanted with marrow from an unrelated donor (MUD). In contrast, the remaining four patients converted to an autologous pattern. Three out of these four patients had an early autologous haematological reconstitution reaching a neutrophil level >0.5 x 10(9)/l at days 27, 33 and 37 after transplant, respectively. In all three of these patients, chimaerism analysis demonstrated an early appearance of donor cells (i.e. within 35 d after UCB transplant) showing a transient full donor (one case) or mixed chimaerism condition (two cases). Despite the early autologous haemopoietic reconstitution, one of the three patients died of GVHD at day 60, which was explained by the demonstration of low levels of donor lymphoid cells. In the MUD group all nine patients converted to a persistent full donor pattern with haematological reconstitution, accompanied in two of them by transient mixed chimaerism lasting to days 60 and 270 after transplant. Our data show that monitoring of chimaerism may predict graft failure with or without early autologous haemopoietic reconstitution in patients receiving unrelated UCB transplants. Furthermore, chimaerism analysis may identify, in patients with autologous reconstitution, those at risk of severe GVHD in whom immunosuppressive therapy should not be discontinued.
Assuntos
Transplante de Medula Óssea/métodos , Sangue Fetal , Neoplasias Hematológicas/terapia , Adolescente , Criança , Feminino , Sobrevivência de Enxerto , Neoplasias Hematológicas/genética , Humanos , Masculino , Estudos Prospectivos , Quimeras de Transplante , Transplante AutólogoRESUMO
In the last 3 years, 14 children with high-risk leukemia (11 ALL, 2 AML and 1 CML) underwent cord blood transplantation from unrelated HLA-mismatched donors at a median of 99 days from the start of search. Eight patients were transplanted in second CR, one in accelerated phase, three at relapse and two patients in first CR. Conditioning regimen (fractionated TBI, etoposide, CY and anti-lymphocyte serum) and prophylaxis of GVHD (CsA and 6-methylprednisolone) were identical for all patients. Neutrophils >0.5x10(9)/l were reached at a median of 33 days from transplant, but in four cases we observed an autologous hematopoietic reconstitution (three spontaneous, one after autologous BM rescue). Acute and chronic GVHD were observed in 10/14 and 3/8 evaluable cases, respectively. Three patients died of transplant-related toxicity and three patients relapsed. The probabilities of event-free, disease-free and overall survival were 50, 53 and 64%, respectively. Cord blood transplant from HLA-mismatched unrelated donor is a valid option for the treatment of children with high-risk leukemia. With our eligibility criteria, conditioning regimen and prophylaxis of graft-versus-host disease, the main obstacles to successful transplant were represented by graft failure and fatal acute GVHD.
Assuntos
Sangue Fetal , Transplante de Tecido Fetal , Antígenos HLA/sangue , Leucemia/terapia , Adolescente , Criança , Pré-Escolar , Feminino , Transplante de Tecido Fetal/efeitos adversos , Transplante de Tecido Fetal/imunologia , Doença Enxerto-Hospedeiro/etiologia , Teste de Histocompatibilidade , Humanos , Leucemia/epidemiologia , Masculino , Fatores de Risco , Bancos de Tecidos , Doadores de Tecidos , Quimeras de Transplante , Resultado do TratamentoRESUMO
Umbilical cord blood (UCB) transplant represents a promising therapeutic approach, nevertheless this procedure has been so far almost exclusively used in pediatric patients because of the reduced volume of UCB units. The availability of larger numbers of early and late hematopoietic progenitors by ex vivo amplification procedure may allow the use of UCB in adults and improve the rate and time to engraftment. We describe a stroma-free liquid culture system that induces a 10-fold increase of CD34+ cells and hematopoietic progenitors after 8 days in vitro amplification. The presence of flt3L is essential to preserve and amplify the early stem cell compartment identified by the phenotype CD34+Thy-1+CD45RO+.
Assuntos
Antígenos CD34/análise , Compartimento Celular/efeitos dos fármacos , Sangue Fetal/citologia , Células-Tronco Hematopoéticas/efeitos dos fármacos , Proteínas de Membrana/farmacologia , Adulto , Contagem de Células Sanguíneas , Células Cultivadas , Sangue Fetal/química , Células-Tronco Hematopoéticas/citologia , Humanos , Antígenos Comuns de Leucócito/análise , Fenótipo , Antígenos Thy-1/análiseRESUMO
Ten consecutive children with high risk leukemia have been submitted to UCB transplant from unrelated HLA mismatched donors. All patients received an identical regimen for conditioning and GVHD prophylaxis. The median dose of viable nucleated cells infused was 2.6 x 10(6)/kg b.w. Among the nine patients evaluable for engraftment the hematopoiesis was of full donor origin in six patients and autologous in three. At a median follow-up of 9 months, six of nine (67%) patients are alive in CR.
Assuntos
Sangue Fetal , Transplante de Células-Tronco Hematopoéticas , Leucemia/terapia , Adolescente , Criança , Pré-Escolar , Feminino , Sangue Fetal/imunologia , Doença Enxerto-Hospedeiro/imunologia , Doença Enxerto-Hospedeiro/prevenção & controle , Hematopoese/imunologia , Células-Tronco Hematopoéticas/imunologia , Teste de Histocompatibilidade , Humanos , Masculino , Fatores de Risco , Condicionamento Pré-Transplante , Resultado do TratamentoRESUMO
Twelve consecutive children with high-risk leukemia have been submitted to UCB transplant from unrelated 1 or 2 loci HLA-mismatched donor. All patients received an identical regimen for conditioning and GVHD prophylaxis. The median dose of viable nucleated cells infused was 2.8 x 10(7)/kg bw (range 1.4-7.9). Of 11 patients evaluable for engraftment, the hematopoiesis was of full donor origin in seven patients and autologous in four. The probability of disease-free survival at 1 and 2 years from UCB transplant is 60 and 42%, respectively.
Assuntos
Sangue Fetal , Transplante de Células-Tronco Hematopoéticas , Leucemia/terapia , Adolescente , Criança , Pré-Escolar , Intervalo Livre de Doença , Feminino , Transplante de Tecido Fetal , Teste de Histocompatibilidade , Humanos , Masculino , Transplante Homólogo , Resultado do TratamentoAssuntos
Parto Obstétrico , Sangue Fetal/citologia , Coleta de Amostras Sanguíneas , Feminino , Humanos , GravidezRESUMO
From 1990 to 1994, 3 patients with de novo acute myeloid leukemia (AML) in whom light microscopy and cytochemistry suggested a FAB subtype M3 variant were observed at our Institute. Immunophenotype showed HLA-DR-, CD13+, CD33+, CD2+, CD9+; promyelocytic features were also detected by electron microscopy. However, leukemic cells lacked both translocation t(15;17) and RAR alpha/PML genes rearrangement. These cases were considered to be 'M2 atypical' subtypes and they contribute to point out how cytogenetics and molecular biology are mandatory for a correct diagnosis of acute promyelocytic leukemia (APL) particularly because therapy with all trans retinoic acid (ATRA) is now the best treatment for APL. Nevertheless these 3 cases indicate that the atypical M2 subtype may be confused with the M3v if only cytochemistry, immunophenotype and electron microscopy are used in the defining the FAB subtypes.
Assuntos
Leucemia Mieloide Aguda/diagnóstico , Leucemia Promielocítica Aguda/diagnóstico , Proteínas de Neoplasias , Proteínas Nucleares , Adulto , Diagnóstico Diferencial , Feminino , Humanos , Cariotipagem , Masculino , Proteína da Leucemia Promielocítica , Receptores do Ácido Retinoico/genética , Receptor alfa de Ácido Retinoico , Fatores de Transcrição/genética , Translocação Genética , Proteínas Supressoras de TumorRESUMO
Several immunological abnormalities have been observed in ataxia-telangiectasia (AT), the most consistent being defects of immunoglobulin isotypes, decreased T-cell numbers, and reduced proliferative responses to mitogens. We examined the distribution of T lymphocytes expressing distinctive surface Ag characteristic of "naive" (CD45RA+) and "memory" (CD29+, CD45RO+) T cells, in both CD4+ and CD8+ (bright and dim) lymphocytes from 13 AT patients, compared with healthy age-matched controls. We found that, irrespective of age, patients with AT had a severe deficiency of CD4+/CD45RA+ lymphocytes. This decrease accounted for the reduction of total CD4+ cells, since the absolute numbers of memory CD4+ cells were not significantly different in AT and in controls. Functional tests revealed poor proliferative responses to phytohemagglutinin and normal responses to soluble Ag (tetanus toxoid) in AT patients. These data fit with the distribution of naive and memory cells, which are known to respond predominantly to mitogens or to recall Ag, respectively. CD45RA molecules were normally expressed on CD8+ lymphocytes. This rules out a generalized defect of regulation or differential splicing as the cause of defective expression of CD45RA on CD4+ cells. The selective deficiency of CD4+CD45RA+ may provide a cellular basis for some functional T-cell abnormalities of AT patients. Furthermore, it might practically serve for an early, or even prenatal, diagnosis of this disease.
Assuntos
Antígenos CD/imunologia , Ataxia Telangiectasia/imunologia , Linfócitos T CD4-Positivos/imunologia , Antígenos de Histocompatibilidade/imunologia , Adolescente , Adulto , Criança , Pré-Escolar , Citometria de Fluxo , Humanos , Imunofenotipagem , Integrina beta1 , Antígenos Comuns de Leucócito , Ativação Linfocitária/imunologia , Glicoproteínas de Membrana/imunologia , Fosfoproteínas Fosfatases/imunologia , Linfócitos T Reguladores/imunologiaAssuntos
Proteínas Sanguíneas/análise , Eosinófilos/metabolismo , Infecções por HIV/sangue , HIV-1 , Ribonucleases , Infecções Bacterianas/sangue , Proteínas Granulares de Eosinófilos , Infecções por HIV/imunologia , Soropositividade para HIV/sangue , Soropositividade para HIV/imunologia , Humanos , Imunoglobulinas/análise , Viroses/sangueRESUMO
Atopic dermatitis (AD) is a chronic inflammatory disease of the skin, frequently associated with a family history of atopy, raised serum IgE levels and other immunological abnormalities. Both eosinophils and their basic proteins have been detected in the skin lesions of AD patients. We measured the levels of eosinophil cationic protein (ECP) in sera of 24 children with AD and found them to be increased, compared to nonatopic controls, both children and adults. High ECP values were also obtained in 3 patients with the hyper-IgE syndrome. However, no direct relationship between IgE and ECP serum levels could be established. We found no correlation between serum ECP and the number of circulating eosinophils, suggesting that part of ECP was produced by cells infiltrating the tissues. Measurement of ECP might represent a noninvasive tool to assess the activity of AD in relation to eosinophil involvement in this disease.